Log on / register
Feedback | Support | My details
The molecular portraits of breast tumors are conserved across microarray platforms.
Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, Liu Y, Nanda R, Tretiakova M, Ruiz Orrico A, Dreher D, Palazzo JP, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush JF, Ellis MJ, Olopade OI, Bernard PS, Perou CM
BMC Genomics 2006, 7:96
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.
Lu Y, Lemon W, Liu PY, Yi Y, Morrison C, Yang P, Sun Z, Szoke J, Gerald WL, Watson M, Govindan R, You M
PLoS Med 2006 Dec, 3:e467
[PubMed Central] [PubMed] [Related articles]

2.
The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans.
Welm AL, Sneddon JB, Taylor C, Nuyten DS, van de Vijver MJ, Hasegawa BH, Bishop JM
Proc Natl Acad Sci U S A 2007 May 1, 104:7570-5
[PubMed Central] [PubMed] [Related articles]

3.
Lung metastasis genes couple breast tumor size and metastatic spread.
Minn AJ, Gupta GP, Padua D, Bos P, Nguyen DX, Nuyten D, Kreike B, Zhang Y, Wang Y, Ishwaran H, Foekens JA, van de Vijver M, Massagué J
Proc Natl Acad Sci U S A 2007 Apr 17, 104:6740-5
[PubMed Central] [PubMed] [Related articles]

4.
Breast cancer: origins and evolution.
Polyak K
J Clin Invest 2007 Nov, 117:3155-63
[PubMed Central] [PubMed] [Related articles]

5.
A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling.
Julka PK, Chacko RT, Nag S, Parshad R, Nair A, Oh DS, Hu Z, Koppiker CB, Nair S, Dawar R, Dhindsa N, Miller ID, Ma D, Lin B, Awasthy B, Perou CM
Br J Cancer 2008 Apr 22, 98:1327-35
[PubMed Central] [PubMed] [Related articles]

6.
Epidemiology of basal-like breast cancer.
Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM
Breast Cancer Res Treat 2008 May, 109:123-39
[PubMed Central] [PubMed] [Related articles]

7.
Genomic signatures of breast cancer metastasis.
Urquidi V, Goodison S
Cytogenet Genome Res 2007, 118:116-29
[PubMed Central] [PubMed] [Related articles]

8.
Unraveling the microenvironmental influences on the normal mammary gland and breast cancer.
Weigelt B, Bissell MJ
Semin Cancer Biol 2008 Oct, 18:311-21
[PubMed Central] [PubMed] [Related articles]

9.
Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ, Tao Y, Luo J, A'Hern R, Evans DB, Bhatnagar AS, Chaudri Ross HA, von Kameke A, Miller WR, Smith I, Eiermann W, Dowsett M
J Natl Cancer Inst 2008 Oct 1, 100:1380-8
[PubMed Central] [PubMed] [Related articles]

10.
In vitro and in vivo analysis of B-Myb in basal-like breast cancer.
Thorner AR, Hoadley KA, Parker JS, Winkel S, Millikan RC, Perou CM
Oncogene 2009 Feb 5, 28:742-51
[PubMed Central] [PubMed] [Related articles]

11.
Biological convergence of cancer signatures.
Solé X, Bonifaci N, López-Bigas N, Berenguer A, Hernández P, Reina O, Maxwell CA, Aguilar H, Urruticoechea A, de Sanjosé S, Comellas F, Capellá G, Moreno V, Pujana MA
PLoS One 2009, 4:e4544
[PubMed Central] [PubMed] [Related articles]

12.
Correlation signature of the macroscopic states of the gene regulatory network in cancer.
Slavov N, Dawson KA
Proc Natl Acad Sci U S A 2009 Mar 17, 106:4079-84
[PubMed Central] [PubMed] [Related articles]

13.
Data perturbation independent diagnosis and validation of breast cancer subtypes using clustering and patterns.
Alexe G, Dalgin GS, Ramaswamy R, Delisi C, Bhanot G
Cancer Inform 2007, 2:243-74
[PubMed Central] [PubMed] [Related articles]

14.
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, Perou CM, Ellis MJ, Nielsen TO
J Natl Cancer Inst 2009 May 20, 101:736-50
[PubMed Central] [PubMed] [Related articles]

15.
Prediction of breast cancer metastasis by genomic profiling: where do we stand?
Pfeffer U, Romeo F, Noonan DM, Albini A
Clin Exp Metastasis 2009, 26:547-58
[PubMed Central] [PubMed] [Related articles]

16.
A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response.
Chandriani S, Frengen E, Cowling VH, Pendergrass SA, Perou CM, Whitfield ML, Cole MD
PLoS One 2009, 4:e6693
[PubMed Central] [PubMed] [Related articles]

17.
Can survival prediction be improved by merging gene expression data sets?
Yasrebi H, Sperisen P, Praz V, Bucher P
PLoS One 2009, 4:e7431
[PubMed Central] [PubMed] [Related articles]

18.
Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis.
Barnes MG, Grom AA, Thompson SD, Griffin TA, Pavlidis P, Itert L, Fall N, Sowders DP, Hinze CH, Aronow BJ, Luyrink LK, Srivastava S, Ilowite NT, Gottlieb BS, Olson JC, Sherry DD, Glass DN, Colbert RA
Arthritis Rheum 2009 Jul, 60:2102-12
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 35 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.